Hledání v detailu akcií
Moje portfolio
Nastavit Oblíbené, nastavit Portfolio
Oblíbené tituly
select
NázevNejlepší
nákup
Nejlepší
prodej
Změna
(%)
ČEZ1150-4,09
KB-0,40
PKN124,66124,76-3,28
Msft379,3379,360,13
Nokia11,7911,805-2,48
IBM249,66249,71-4,83
Mercedes-Benz Group AG44,67544,69-4,60
PFE25,2125,22-2,70
18.06.2026 22:00:00
Indexy online
AD Index online
select
AD Index online
 

  • 18.06.2026 21:58:17
CVS (CVS, NY Consolidated)
Poslední obchod Změna (%) Změna (USD) Objem obchodů (USD)
98,11 -1,06 -1,05 505 876 981
After-hours18.06.2026 21:58:17
Poslední obchod Nákup / Prodej Změna (%) Změna (USD)
98,11 98,11 98,12 -1,06 -1,05
R - Real-Time data si mohou aktivovat klienti Patria Plus / Investor Plus ZDE.

 
  • Poslední aktualizace: 18.06.2026
Popis společnosti

Business Summary: CVS Health Corporation is a health solutions company. The Company's segments include Health Care Benefits, Health Services, Pharmacy & Consumer Wellness and Corporate/Other. The Health Care Benefits segment offers a broad range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental and behavioral health plans, PDPs and Medicaid health care management services. The Health Services segment provides a full range of pharmacy benefit management (PBM) solutions through its CVS Caremark operations and delivers health care services in its medical clinics, virtually, and in the home. The Pharmacy & Consumer Wellness segment dispenses prescriptions in its CVS Pharmacy retail locations and, through its infusion operations, provides ancillary pharmacy services including pharmacy patient care programs, and vaccination administration, and sells a wide assortment of health and wellness products and general merchandise.
Financial Summary: BRIEF: For the three months ended 31 March 2026, CVS Health Corp revenues increased 6% to $100.43B. Net income increased 65% to $2.94B. Revenues reflect Health Services segment increase of 11% to $48.24B, Health Care Benefits segment increase of 3% to $35.97B, Comp. Store Sales (Growth - %) - Front increase from -0.3 to 1.2%, Retail Sales-Retail Pharmacy increase of less than 1% to $26.12B.



  • Poslední aktualizace: 18.06.2026
Management společnosti
Data nejsou k dispozici